-Phase 1 ATLAS trial to evaluate TK-6302 in patients with advanced PRAME-positive solid tumors authorized for initiation SAN FRANCISCO and BERLIN, March 03, 2026 (GLOBE NEWSWIRE) -- T-knife ...

SAN FRANCISCO and BERLIN, March 03, 2026 (GLOBE NEWSWIRE) -- T-knife Therapeutics, Inc., a biopharmaceutical company developing next-generation T cell therapies to fight cancer, today announced the ...

Elysse Bell is a finance and business writer for Investopedia. She writes about small business, personal finance, technology, and more. Dr. JeFreda R. Brown is a financial consultant, Certified ...

If your starter word contains a rarely used letter, rethink your strategy. Here are the most commonly used letters in the alphabet. CNET editor Gael Fashingbauer Cooper, a journalist and pop-culture ...

NEW DELHI: The Delhi High Court on Wednesday came down heavily on a Public Interest Litigation (PIL) seeking to restrain the Board of Control for Cricket in India (BCCI) from referring to its players ...